Close X
Wednesday, December 4, 2024
ADVT 
International

4 men charged with murdering Indian-origin delivery driver in UK

Darpan News Desk IANS, 28 Aug, 2023 01:11 PM
  • 4 men charged with murdering Indian-origin delivery driver in UK

London, Aug 28 (IANS) Four men have been charged with murdering a 23-year-old Indian-origin delivery driver who died after being ambushed by a machete-wielding gang in western England, police said.

Aurman Singh, who worked with Dynamic Parcel Distribution, died on the spot while he was delivering parcels in Berwick Avenue in Shrewsbury on August 21.

He could not be saved inspite of the best efforts of emergency services who had rushed to the crime scene.

The West Mercia Police have arrested and charged Arshdeep Singh, 24, of Tipton, Jagdeep Singh, 22, of Dudley, Shivdeep Singh, 26, and Manjot Singh, 24, both of Smethwick in connection with the murder.

The four accused were presented before the Magistrates Court on August 26, police said, adding that a fifth man, who was arrested on suspicion of assisting an offender, has been released on police bail.

Witnesses told The Sun that they saw men armed with machetes, baseball bats and a shovel after a car was seen parked up in the area from 11 a.m. on the day of murder.

Senior Investigating Officer, Detective Chief Inspector Mark Bellamy reassured local residents those suspected of being involved are not local to Shrewsbury or the wider West Mercia Police area.

“Our investigation is underway with officers carrying out a number of enquiries to establish the circumstances that led to Aurman’s murder," Bellamy had said.

“We know Aurman was a delivery person however at this stage we do not believe this was the motive for his death and we are not investigating this as a robbery."

Aurman's family said in a statement released by the West Mercia Police that there are no words that could ever explain the impact this tragedy has had on them.

"Today a mother will grow old without her son. A sister will grow up without her brother. We don't want what has happened to us to happen to another family. We would like to thank the police for conducting their investigation diligently and supporting us through this tough time."

MORE International ARTICLES

Extra safety scrutiny planned as virus vaccine worries grow

Extra safety scrutiny planned as virus vaccine worries grow
The poll from The Associated Press-NORC Center for Public Affairs Research found only 46% of Americans want a COVID-19 vaccine and another 29% are unsure.

Extra safety scrutiny planned as virus vaccine worries grow

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19